A 0 1 0 1 O
contrast 2 10 2 10 B-treatment
- 10 11 10 11 I-treatment
enhanced 11 19 11 19 I-treatment
MRI 20 23 20 23 I-treatment
scan 24 28 24 28 I-treatment
showing 29 36 29 36 O
= 37 38 37 38 O
or 39 41 39 41 O
> 42 43 42 43 O
4 44 45 44 45 B-lower_bound
brain 46 51 46 51 B-clinical_variable
metastases 52 62 52 62 I-clinical_variable

Age 0 3 63 66 B-age
> 4 5 67 68 O
/=18 5 9 68 72 O
years 10 15 73 78 I-lower_bound
of 16 18 79 81 O
age 19 22 82 85 B-age

Greater 0 7 86 93 O
than 8 12 94 98 O
10 13 15 99 101 B-lower_bound
brain 16 21 102 107 B-cancer
metastases 22 32 108 118 I-cancer

KPS 0 3 119 122 B-clinical_variable
> 4 5 123 124 O
/= 5 7 124 126 O
70 8 10 127 129 B-lower_bound

Patient 0 7 130 137 O
must 8 12 138 142 O
have 13 17 143 147 O
a 18 19 148 149 O
graded 20 26 150 156 B-clinical_variable
prosnostic 27 37 157 167 I-clinical_variable
score 38 43 168 173 I-clinical_variable
( 44 45 174 175 I-clinical_variable
GPA 45 48 175 178 I-clinical_variable
) 48 49 178 179 I-clinical_variable
score 50 55 180 185 I-clinical_variable
0.5 56 59 186 189 B-lower_bound
or 60 62 190 192 O
greater 63 70 193 200 O

Postoperative 0 13 201 214 O
patients 14 22 215 223 O
with 23 27 224 228 O
resected 28 36 229 237 O
brain 37 42 238 243 B-cancer
metastases 43 53 244 254 I-cancer
are 54 57 255 258 O
eligible 58 66 259 267 O

Pregnant 0 8 268 276 B-pregnancy

Primary 0 7 277 284 O
lesion 8 14 285 291 O
with 15 19 292 296 O
radiosensitive 20 34 297 311 O
histology 35 44 312 321 O
( 45 46 322 323 O
i.e. 46 50 323 327 O
, 50 51 327 328 O
small 52 57 329 334 B-cancer
cell 58 62 335 339 I-cancer
carcinoma 63 72 340 349 I-cancer
, 72 73 349 350 O
germ 74 78 351 355 B-cancer
- 78 79 355 356 I-cancer
cell 79 83 356 360 I-cancer
tumors 84 90 361 367 I-cancer
, 90 91 367 368 O
lymphoma 92 100 369 377 B-cancer
, 100 101 377 378 O
leukemia 102 110 379 387 B-cancer
, 110 111 387 388 O
and 112 115 389 392 O
multiple 116 124 393 401 B-cancer
myeloma 125 132 402 409 I-cancer
) 132 133 409 410 O

